All IDC research is © 2015 by IDC. All rights reserved. All IDC materials are licensed with IDC's permission and in no way does the use or publication of IDC research indicate IDC's endorsement of Dassault Système’s products/or strategies.

AN IDC INFOGRAPHIC, SPONSORED BY DASSAULT SYSTÈMES

Life Sciences Research

Challenges Facing the Research Ecosystem

Life Sciences Industry Goals

Why Biologics is Increasingly Important

BIOVIA Biologics for Discovery, Development and Manufacturing

The R&D ecosystem is becoming increasingly complex

It’s getting harder to:

Quality

51%

Efficiency InnovationReduce variability in

processes and products;quality by design for

better process understanding

Harmonization, standardization,

integration,externalization

Global collaboration, new technologies,

knowledge management, shift toward biologics

Reasons for growth:

Users report up to 50% gains in efficiency and throughput, as well as improved quality of results with this type of solution.

Learn more about challenges facing biologics discovery researchers and product developers, and Dassault Systèmes' BIOVIA Biologics solution, by downloading the IDC white paper, "Looking

Forward: The Case for Intelligent Design (and Infrastructure) in Life Science Biologics R&D.”

Intelligent Infrastructure for

Access new research

capabilities

Work well with global

teams

Pick the right tool for the right task Visualize and

share complex models

Standardize experimentation

Share and transfer data internally and externally

Leverage rapid growth of data,

information, and knowledge

Superior efficacy

Premium pricing

12-year exclusivity (U.S.)Satisfies previously unmet clinical

needs

Discoveryand Analysis

Registrationand Sample

Management

PredictiveAnalytics

ProcessProductionOperations

WorkflowSupport

RegulatoryQuality

Compliance

BioprocessDocumentation

and DataManagement

BIOVIAFOUNDATION

of the top 100 prescription and OTC drug sales will be biologics by 2018*

*EvaluatePharma

6of the top-selling drugs in 2014 were biologics*